Abstract
The article highlights the complexity of innovative processes and their demands on individual abilities using the example of market access for innovative pharmaceuticals, which she explains in detail. At a time when innovative companies must find flexible solutions to ever-changing market dynamics, the ability of connectivity constitutes a key success factor. Companies’ strategic orientation and the operational goals of individual employees require continuous review and (re-)alignment. In the era of connectivity, strategies, organizational structures, and connected tasks of single employees must enable agility in order to create successful innovative processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Efpia. (2017). Retrieved from https://www.efpia.eu/about-medicines/use-of-medicines/hta-relative-efficacy-assessment/
EUnetHTA. (2017). Retrieved from http://www.eunethta.eu/activities/joint-action-3/jointaction31/eunethta-joint-action-3-2016-2020
European Commission. (2013). Retrieved from http://ec.europa.eu/health//sites/health/files/systems_performance_assessment/docs/erp_reimbursement_medicinal_products_en.pdf
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schmidt, M. (2020). Connectivity Challenges in the Pharmaceutical Industry: A Case Study. In: Wollmann, P., KĂĽhn, F., Kempf, M. (eds) Three Pillars of Organization and Leadership in Disruptive Times. Future of Business and Finance. Springer, Cham. https://doi.org/10.1007/978-3-030-23227-6_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-23227-6_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23226-9
Online ISBN: 978-3-030-23227-6
eBook Packages: Business and ManagementBusiness and Management (R0)